A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT06764485 · RECRUITING
Trial details
- NCT number
- NCT06764485
- Sponsor
- Celgene
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-13
- Primary completion
- 2027-09-12
- Enrollment
- 960
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.